Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
15.6M
-
Shares change
-
+15.6M
-
Total reported value, excl. options
-
$117M
-
Value change
-
+$117M
-
Number of buys
-
55
-
Price
-
$7.50
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q1 2018
55 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q1 2018.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.6M shares
of 79.2M outstanding shares and own 19.69% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (3.34M shares), RA CAPITAL MANAGEMENT, LLC (2.69M shares), Bain Capital Life Sciences Investors, LLC (1.99M shares), Boxer Capital, LLC (750K shares), Cormorant Asset Management, LP (686K shares), RTW INVESTMENTS, LP (676K shares), BlackRock Inc. (639K shares), BAKER BROS. ADVISORS LP (588K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (550K shares), and EVENTIDE ASSET MANAGEMENT, LLC (400K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.